ACR 2020 Archives - Medical Conferences

Home > Rheumatology > ACR 2020

American College of Rheumatology 5-9 November 2020

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, UK

ACR 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Late-Breaking News

Gout treatment with febuxostat: no higher cardiovascular mortality

Presented By

Prof. Thomas MacDonald, University of Dundee, UK

New agent with great potential for the treatment of giant cell arteritis in the pipeline

Presented By

Dr Maria Cinta Cid, Hospital Clínic of Barcelona, Spain

Autotaxin inhibitor successful in the first trial in diffuse cutaneous systemic sclerosis

Presented By

Prof. Dinesh Khanna, University of Michigan Scleroderma Program, USA

JAK inhibition as a treatment option for ankylosing spondylitis

Presented By

Prof. Atul Deodhar, Oregon Health & Science University, USA

Spotlight on Rheumatoid Arthritis

Persuasive long-term results for JAK inhibition in rheumatoid arthritis

Presented By

Prof. Josef Smolen, Medical University of Vienna, Austria

Rheumatoid arthritis: new EULAR treatment guidelines

Presented By

Prof. Daniel Aletaha, Medical University Vienna, Austria

Rheumatoid arthritis and interstitial lung disease: a deadly combination

Presented By

Prof. Joan Bathon, Columbia University, USA

COVID-19 – What Rheumatologists Need to Know

COVID-19 in patients with rheumatic disease: most report mild disease

Presented By

Dr Akhil Sood, University of Texas Medical Branch, USA

Poor disease control: a risk factor for severe COVID-19

Presented By

Prof. Rebecca Grainger, University of Otago, New Zealand

No heightened outcome risk for rheumatic patients with COVID-19

Presented By

Dr Naomi Serling-Boyd, Massachusetts General Hospital, USA

What Is Hot in Lupus Nephritis?

Lupus nephritis biomarkers: moving toward an omic-driven approach

Presented By

Prof. Chaim Putterman, Albert Einstein College of Medicine, USA

Lupus nephritis: new therapies on the horizon in 2020

Presented By

Prof. Joan T. Merrill, Oklahoma Medical Research Foundation, USA

Spondyloarthritis – The Beat Goes On

Signs of benefit for T2T in axial spondyloarthritis

Artificial intelligence can help in the diagnosis of axSPA

Presented By

Prof. Denis Poddubnyy, Charité Universitätsmedizin Berlin, Germany

Resolution of dactylitis or enthesitis is associated with improvements in joint and skin symptoms

Presented By

Prof. Dennis McGonagle, University of Leeds, UK

Promising novel treatment option for psoriatic arthritis

Presented By

Prof. Philip J. Mease, University of Washington, USA

How to Diagnose Large Vessel Vasculitis: Promises and Pitfalls

How to choose imaging modalities in large vessel vasculitis

Presented By

Dr Anisha Dua, Northwestern Medical Group, USA

Diagnosis of large vessel vasculitis with imaging

Presented By

Dr Peter Grayson, National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, USA

Osteoarthritis – Novel Developments

Knee osteoarthritis patients with indicators of inflammation could profit from methotrexate

Presented By

Prof. Biswadip Ghosh, Institute of Post Graduate Medical Education and Research, India

Anticoagulation with vitamin K antagonist is associated with risk of knee and hip replacement

Presented By

Dr Priyanka Ballal, Boston University Medical Center, USA

Osteoporosis – New Data

Bisphosphonate use: Asian American women have a smaller treatment benefit

Presented By

Prof. Jinoos Yazdany, University of California San Francisco, USA

Inflammatory disease as a risk factor for fractures

Presented By

Dr Giovanni Adami, University of Verona, Italy

Best of the Posters

No progression of osteoarthritis with corticosteroid injections

Presented By

Dr Justin J. Bucci, Boston University School of Medicine, USA

No elevated risk for influenza AE in tofacitinib-treated RA patients

Hydroxychloroquine use: no indication for arrhythmias in RA and SLE patients

Presented By

Dr Elizabeth Park, Columbia University Irving Medical Center, USA

Children with rheumatic disease have no greater risk of a COVID-19 infection

Presented By

Dr Jonathan S. Hausmann, Harvard Medical School and Boston Children’s Hospital, USA

Insufficient antimalarial supply for rheumatic disease treatment in the early COVID-19 pandemic

Presented By

Ms Emily Sirotich, COVID‐19 Global Rheumatology Alliance Steering Committee and McMaster University, Canada

Table of Contents

Featured articles

Late-Breaking News

Spotlight on Rheumatoid Arthritis

COVID-19 – What Rheumatologists Need to Know

What Is Hot in Lupus Nephritis?

Spondyloarthritis – The Beat Goes On

How to Diagnose Large Vessel Vasculitis: Promises and Pitfalls

Osteoarthritis – Novel Developments

Osteoporosis – New Data

Best of the Posters